Practice parameters for antibiotic prophylaxis to prevent infective
endocarditis or infective prosthesis during colon and rectal endoscopy.
SOURCE(S):
Dis Colon Rectum 2000 Sep;43(9):1193-200 [61 references]
Practice Parameters for Antibiotic Prophylaxis
Bacterial endocarditis is a serious, potentially fatal condition that may be
associated with endoscopic procedures. Antibiotic prophylaxis has been used
to prevent endocarditis, but does involve risks. Endoscopists must assess
the evidence and weigh the risks and benefits. It is the consensus of The
Standards Task Force that antibiotic prophylaxis be considered only for the
high-risk groups.
Conditions Associated with Endocarditis
High risk
*         Prosthetic cardiac valves
*         History of endocarditis
*         Surgically constructed systemic pulmonary shunts
*         Complex cyanotic congenital heart disease
*         Vascular grafts (first 6 months after implantation)
Moderate risk
*         Most other cardiac malfunctions
*         Acquired valvular dysfunction
*         Hypertrophic cardiomyalgia
*         Mitral valve prolapse with valvular regeneration or thickened
valves or both
Low risk
*         Vascular graft material (6 months after implantation)
*         Orthopedic prosthesis
*         Central nervous system ventricular shunts
*         Penile prosthesis
*         Intraocular lens
*         Pacemakers
*         Local tissue augmentation material
*         Isolated secundum atrial septal defect
*         Previous coronary bypass
*         Mitral valve prolapse without valvular degeneration
*         Physiologic heart murmurs
*         Previous rheumatic fever without valvular dysfunction
*         Cardiac pacemaker
It is the consensus of The Standards Task Force that antibiotic prophylaxis
be considered only for the high-risk groups.
Nonvalvular and Noncardiac Prosthesis
Prophylactic Regimens
It is impossible to make recommendations for all clinical situations.
Practitioners must choose the anti-biotic and determine the dosage based on
the special circumstances of each case. Adult prophylactic regimens listed
in the table below are representative of recommendations made by the
American Heart Association (AHA). Although the other organisms may be
cultured after lower endoscopy, enterococcus is the most likely cause of
endocarditis; therefore, the prophylactic regimens are directed primarily
against enterococci.
Adult Prophylactic Regimens:
Drug
Adult Dosage Regimen
Ampicillin, gentamicin, and amoxicillin
Intravenous or intramuscular administration of ampicillin (2.0 g) plus
gentamicin (1.5 mg/kg; not to exceed 120 mg) 30 minutes before procedure,
followed by amoxicillin (1 g) orally 6 hours after initial dose or
ampicillin 1 g intramuscularly or intravenously.
Vancomycin and gentamicin*
Intravenous administration of vancomycin (1.0 g) over 1 to 2 hours plus
intravenous or intramuscular administration of gentamicin (1.5 mg/kg; not to
exceed 120 mg), complete infusion within 30 minutes of starting procedure.
Amoxicillin** or ampicillin
Amoxicillin 2 g orally or ampicillin 2 g intramuscularly or intravenously
within 30 minutes of starting procedure.
*Ampicillin or amoxicillin or penicillin-allergic regimen.
**Alternative moderate-risk regimen.
CLINICAL ALGORITHM(S):
None provided
DEVELOPER(S):
American Society of Colon and Rectal Surgery (ASCRS) - Medical Specialty
Society
COMMITTEE:
Standards Task Force, American Society of Colon and Rectal Surgeons
GROUP COMPOSITION:
Task Force Members: Greg Oliver, M.D., Project Director, Ann Lowry, M.D.,
Committee Chair, Anthony Vernava, M.D., Vice Chairman, Terry Hicks, M.D.,
Council Representative, Marcus Burnstein, M.D., Frederick Denstman, M.D.,
Victor Fazio, M.D., Bruce Kerner, M.D., Richard Moore, M.D., Walter Peters,
M.D., Theodore Ross, M.D., Peter Senatore, M.D., Clifford Simmang, M.D.,
Steven Wexner, M.D., W. Douglas Wong, M.D.
ENDORSER(S):
Not stated
GUIDELINE STATUS:
This is the current release of the guideline. This guideline updates a
previously issued guideline (Practice parameters for antibiotic prophylaxis
to prevent infective endocarditis or infected prosthesis during colon and
rectal endoscopy. The American Society of Colon and Rectal Surgeons. Dis
Colon Rectum 1992 Mar;35[3]:277).
GUIDELINE AVAILABILITY:
Electronic copies: Available from the American Society of Colon and Rectal
Surgeons (ASCRS) Web site <http://www.fascrs.org/ascrspp-appie.html> .
Print copies: Available from ASCRS, 85 W. Algonquin Road, Suite 550,
Arlington Heights, Illinois 60005.
COMPANION DOCUMENTS:
The following is available:
*         Oliver G, Lowry A, Vernava A, Hicks T, Burnstein M, Denstman F,
Fazio V, Kerner B, Moore R, Peters W, Ross T, Senatore P, Simmang C, Wexner
S, Wong Practice parameters for antibiotic prophylaxis--supporting
documentation. The Standards Task Force. The American Society of Colon and
Rectal Surgeons. Dis Colon Rectum. 2000 Sep;43(9):1194-200.
Electronic copies: Available from the American Society of Colon and Rectal
Surgeons (ASCRS) Web site <http://www.fascrs.org/ascrspp-appie-sd.html> .
Print copies: Available from ASCRS, 85 W. Algonquin Road, Suite 550,
Arlington Heights, Illinois 60005.


Edward E. Rylander, M.D.
Diplomat American Board of Family Practice.
Diplomat American Board of Palliative Medicine.